Suppr超能文献

中国肝细胞癌患者手术切除后与疾病生存相关的因素。

Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma.

作者信息

Qiang Li, Huikai Li, Butt Kelly, Wang P Peter, Hao Xishan

机构信息

Department of Hepatobiliary Surgery, Cancer Hospital of Tianjin Medical University, Tianjin, 300060, China.

出版信息

World J Surg. 2006 Mar;30(3):439-45. doi: 10.1007/s00268-005-0608-6.

Abstract

OBJECTIVE

The aim of this cohort study was to investigate clinical outcome and prognostic factors after surgical resection for hepatocellular carcinoma (HCC).

MATERIALS AND METHODS

A total of 1,157 HCC patients undergoing hepatic resection between 1998 and 2003 were included in this study. Univariate and multivariate analyses were performed to examine factors affecting clinical outcome and recurrence.

RESULTS

Surgical procedures consisted of 1,011 (87.4%) anatomical resections, including 205 (17.7%) extended hepatectomies, 324 (28.0%) hemihepatectomies, 482 (41.7%) segmental resections, and 146 (12.6%) local resections. The results suggest that 56.6% of patients had a recurrence of HCC during the study period and the main recurrence type was intrahepatic (542; 83.1%). The median survival time was 45 months. The 1-, 3- and 5-year overall disease-free survival rates for the study population were 74%, 47%, and 39% respectively.

CONCLUSIONS

The results of proportional hazard analyses suggest that tumor size, number of nodules and vascular invasion were significant predictors for poor survival rates.

摘要

目的

本队列研究旨在调查肝细胞癌(HCC)手术切除后的临床结局和预后因素。

材料与方法

本研究纳入了1998年至2003年间接受肝切除的1157例HCC患者。进行单因素和多因素分析以检查影响临床结局和复发的因素。

结果

手术方式包括1011例(87.4%)解剖性切除,其中205例(17.7%)扩大肝切除术,324例(28.0%)半肝切除术,482例(41.7%)肝段切除术,146例(12.6%)局部切除术。结果表明,56.6%的患者在研究期间出现HCC复发,主要复发类型为肝内复发(542例;83.1%)。中位生存时间为45个月。研究人群的1年、3年和5年总体无病生存率分别为74%、47%和39%。

结论

比例风险分析结果表明,肿瘤大小、结节数量和血管侵犯是生存率低的重要预测因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验